Clinical trial · Observational
The Impact of Melanoma and Drug Treatment in the Real World
NCT03379454CI-TRIAL-00064849completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
An observational, non-interventional registry study to collect real-world data from people living with melanoma and its treatment, which will be available to researchers to further the knowledge of melanoma and improve patient care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Health-Related Quality of Life (HRQL), general
- timeFrame
- Monthly throughout 4 year study duration
- description
- EQ-5D-5L
Secondary outcomes (2)
- measure
- Health-Related Quality of Life (HRQL), oncology
- timeFrame
- Monthly throughout 4 year study duration
- description
- QLQ-C30
- measure
- Health-Related Quality of Life (HRQL), symptoms
- timeFrame
- Monthly throughout 4 year study duration
- description
- PRO-CTCAE
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * adults with melanoma of any stage, resident in the UK with National Health Service (NHS) or Community Health Index (CHI) number, aged 18 and over, current or previous diagnosis of melanoma, willing to use their own smartphone or tablet. Exclusion Criteria: * no specific exclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.